Bedirli et al. [12] believed that sevoflurane pretreatment could diminish the concentrations of inflammatory factors (TNF-α and IL-1β) during ischemia and reperfusion, lessen inflammatory response-induced brain injury, and exert protective effect on the brain, which was consistent with our results. This evidence concerns the gene TNF and ischemia.